Our model demonstrated an accelerated manifestation of both increased tau phosphorylation and fibril formation within a significantly shorter timeframe of 4 weeks, in contrast to the traditional AD cellular models which typically require several months of experimental time. This evidence concerns the gene MAPT and Alzheimer disease.